BIOVIE INC. Contracts & Agreements
57 Contracts & Agreements
- Business Finance (38 contracts)
- Business Operations (1)
- Human Resources (8)
- Mergers & Acquisitions (1)
- Uncategorized (9)
- Form of Placement Agent's Warrant Agreement (included in Exhibit 10.1) (Filed With SEC on October 29, 2024)
- Form of Placement Agent's Warrant Agreement (included in Exhibit 10.1) (Filed With SEC on October 24, 2024)
- Form of Warrant (Filed With SEC on October 24, 2024)
- Form of Placement Agent's Warrant Agreement (included in Exhibit 10.1) (Filed With SEC on October 22, 2024)
- Form of Warrant (Filed With SEC on October 22, 2024)
- Form of Placement Agent's Warrant Agreement (included in Exhibit 10.1) (Filed With SEC on September 24, 2024)
- Form of Common Warrant (Filed With SEC on September 24, 2024)
- Form of Pre-Funded Warrant (Filed With SEC on September 24, 2024)
- Placement Agent Agreement, dated as of March 4, 2024 by and between the Company and the Placement Agent (Filed With SEC on March 4, 2024)
- Form of Common Warrant (Filed With SEC on March 4, 2024)
- Form of Pre-Funded Warrant (Filed With SEC on March 4, 2024)
- Amendment No. 2 to Asset Purchase Agreement, dated January 13, 2023, by and between BioVie Inc. and Acuitas Group Holdings, LLC, and Acuitas Group Holdings, LLC, solely for... (Filed With SEC on February 10, 2023)
- Amended and Restated Registration Rights Agreement, dated August 15, 2022, by and between BioVie Inc. and Acuitas Group Holdings, LLC (Filed With SEC on November 4, 2022)
- Controlled Equity OfferingSM Sales Agreement, dated August 31, 2022, by and among BioVie Inc. Cantor Fitzgerald & Co. and B. Riley Securities, Inc (Filed With SEC on August 31, 2022)
- Securities Purchase Agreement, dated July 15, 2022, by and between the Company and Acuitas Group Holdings, LLC (Filed With SEC on July 18, 2022)
- Form of Common Stock Purchase Warrant (Filed With SEC on July 18, 2022)
- Securities Purchase Agreement, dated July 15, 2022, by and between the Company and Acuitas Group Holdings, LLC (Filed With SEC on July 15, 2022)
- Form of Common Stock Purchase Warrant (Filed With SEC on July 15, 2022)
- Form of Warrant to Purchase Shares of Class A Common Stock of BioVie Inc (Filed With SEC on December 1, 2021)
- Supplement to Loan and Security Agreement, dated November 30, 2021, among BioVie Inc., Avenue Venture Opportunities Fund II, L.P. and Avenue Venture Opportunities Fund, L.P (Filed With SEC on December 1, 2021)
- Loan and Security Agreement, dated November 30, 2021, among BioVie Inc. Avenue Venture Opportunities Fund II, L.P., and Avenue Venture Opportunities Fund, L.P (Filed With SEC on December 1, 2021)
- Employment Agreement Jonathan Adams and Company dated, August 26, 2021 (Filed With SEC on November 10, 2021)
- Employment Agreement Joseph Palumbo and Company, dated September 3, 2021 (Filed With SEC on November 10, 2021)
- Employment Agreement Penelope Markham and Company, dated September 7, 2021 (Filed With SEC on November 10, 2021)
- Employment Agreement Joanne Wendy Kim and Company, dated June 26, 2021 (Filed With SEC on November 10, 2021)
- Employment Offer & Agreement Clarence Ahlem and Company, dated June 18, 2021 (Filed With SEC on November 10, 2021)
- Employment Offer & Agreement Chris Reading and Company, dated June 18, 2021 (Filed With SEC on November 10, 2021)
- Description of Securities (Filed With SEC on August 30, 2021)
- Underwriting Agreement between the Company and ThinkEquity, a division of Fordham Financial Management, Inc., as representatives of the several Underwriters, dated August 8, 2021 (Filed With SEC on August 11, 2021)
- Registration Rights Agreement, dated June 10, 2021, by and between the Company and Acuitas Group Holdings, LLC (Filed With SEC on June 11, 2021)
- Amendment No. 1 to Asset Purchase Agreement, dated May 9, 2021, by and among the Company, NeurMedix, Inc. and Acuitas Group Holdings, LLC (Filed With SEC on May 10, 2021)
- Asset Purchase Agreement, dated April 27, 2021, by and among the Company, NeurMedix, Inc. and Acuitas Group Holdings, LLC (Filed With SEC on April 27, 2021)
- Form of Underwriting Agreement (Filed With SEC on September 8, 2020)
- Description of Securities (Filed With SEC on August 6, 2020)
- BioVie, Inc. Letter Agreement with Acuitas Group Holdings, LLC dated as of July 14, 2020 (Filed With SEC on July 15, 2020)
- BioVie, Inc. Letter Agreement with Acuitas Group Holdings, LLC dated as of April 8, 2020 (Filed With SEC on May 13, 2020)
- Form of Placement Agency Agreement (including form of Placement Agent Warrant) (Filed With SEC on March 11, 2020)
- BioVie, Inc. Letter Agreement with Acuitas Group Holdings, LLC dated as of February 10, 2020 (Filed With SEC on February 13, 2020)
- Form of Common Stock Purchase Warrant (Filed With SEC on October 9, 2019)
- Amendment to Securities Purchase Agreement, dated as of October 9, 2019, by and between BioVie Inc. and Acuitas Group Holdings, LLC (Filed With SEC on October 9, 2019)
- Form of Underwriting Agreement (Filed With SEC on October 4, 2019)
- Warrant Agency Agreement and Form of Warrant offered hereby (Filed With SEC on October 2, 2019)
- Description of Securities (Filed With SEC on September 27, 2019)
- Form of 10% OID Convertible Delayed Draw Debenture (Filed With SEC on September 25, 2019)
- Securities Purchase Agreement dated as of September 24, 2019 (Filed With SEC on September 25, 2019)
- Form of Common Stock Purchase Warrant (Filed With SEC on September 25, 2019)
- Form of Underwriting Agreement (Filed With SEC on August 8, 2019)
- Letter Agreement between Acuitas Group Holdings, LLC and the Company dated June 24, 2019 (Filed With SEC on July 1, 2019)
- Letter Agreement between Acuitas Group Holdings, LLC and the Company dated June 24, 2019 (Filed With SEC on June 28, 2019)
- Employment Agreement between Jonathan Adams and the Company dated, April 11, 2016 (Filed With SEC on April 30, 2019)
- Amendment No. 1 to Employment Agreement between Jonathan Adams and the Company dated July 3, 2018 (Filed With SEC on April 30, 2019)
- Specimen Certificate representing shares of Class A Common Stock (Filed With SEC on April 30, 2019)
- Securities Purchase Agreement, dated as of July 3, 2018, by and among BioVie Inc., Acuitas Group Holdings, LLC and the Purchasers identified therein (Filed With SEC on July 3, 2018)
- Form of Common Stock Purchase Warrant (Filed With SEC on July 3, 2018)
- Common Stock Purchase Agreement, dated January 4, 2017 between BIOVIE, INC. and Aspire Capital Fund, LLC (Filed With SEC on January 5, 2017)
- Registration Rights Agreement, dated January 4, 2017, between BIOVIE, INC. and Aspire Capital Fund, LLC (Filed With SEC on January 5, 2017)
- Agreement and Plan of Merger between Swift Start Corp., NanoAntibiotics, Inc., LAT Acquisition, and LAT Pharma, LLC, dated April 11, 2016 (Filed With SEC on April 15, 2016)
